[1-({4-[(tert-butoxycarbonyl)amino]phenyl}carbonyl)isoquinolin-4-yl] acetic acid | 1233246-59-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: [1-({4-[(tert-butoxycarbonyl)amino]phenyl}carbonyl)isoquinolin-4-yl] acetic acid
• 英文别名: 2-[1-[4-[(2-Methylpropan-2-yl)oxycarbonylamino]benzoyl]isoquinolin-4-yl]acetic acid
• CAS: 1233246-59-7
• 化学式: C₂₃H₂₂N₂O₅
• 分子量: 406.438
• InChiKey: DYQDPWYUPKYSPB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  30
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  [1-({4-[(tert-butoxycarbonyl)amino]phenyl}carbonyl)isoquinolin-4-yl] acetic acid 在 吡啶 、 水 、 三氟乙酸 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 氯仿 为溶剂， 反应 16.0h， 生成 2-[1-[4-[[2-(1-adamantyl)acetyl]amino]benzoyl]isoquinolin-4-yl]acetic acid
  参考文献：
  名称：

  Isoquinoline derivatives as potent CRTH2 antagonists: Design, synthesis and SAR

  摘要：

  In this study, we describe the synthesis and structure-activity relationship (SAR) of a series of isoquinoline chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists. TASP0376377 (15-20), one of the most potent compounds, showed a potent binding affinity (IC50 = 19 nM) in addition to the excellent functional antagonist activity (IC50 = 13 nM). Moreover, the efficacy of this compound in a chemotaxis assay (IC50 = 23 nM) was in good agreement with its potency as a CRTH2 antagonist. In addition, 15-20 exhibited greater selectivity in binding to CRTH2 than to the DP1 prostanoid receptor (IC50 > 1 mu M) or the enzymes COX-1 and COX-2 (IC50 > 10 mu M). (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.025
• 作为产物：
  描述：

  4-tert-butoxycarbonylaminophenylacetonitrile 在 草酰氯 、 水 、 silver(I) acetate 、 sodium hexamethyldisilazane 、 sodium hydroxide 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 氯仿 、 乙腈 为溶剂， 反应 44.0h， 生成 [1-({4-[(tert-butoxycarbonyl)amino]phenyl}carbonyl)isoquinolin-4-yl] acetic acid
  参考文献：
  名称：

  Isoquinoline derivatives as potent CRTH2 antagonists: Design, synthesis and SAR

  摘要：

  In this study, we describe the synthesis and structure-activity relationship (SAR) of a series of isoquinoline chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists. TASP0376377 (15-20), one of the most potent compounds, showed a potent binding affinity (IC50 = 19 nM) in addition to the excellent functional antagonist activity (IC50 = 13 nM). Moreover, the efficacy of this compound in a chemotaxis assay (IC50 = 23 nM) was in good agreement with its potency as a CRTH2 antagonist. In addition, 15-20 exhibited greater selectivity in binding to CRTH2 than to the DP1 prostanoid receptor (IC50 > 1 mu M) or the enzymes COX-1 and COX-2 (IC50 > 10 mu M). (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.025

文献信息

• ISOQUINOLINE DERIVATIVE
  申请人：Takayama Tetsuo

  公开号：US20110288293A1

  公开（公告）日：2011-11-24

  A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

  化合物(I)的分子式或其药学上可接受的盐具有抑制CRTH2的效果，因此可用作预防或治疗哮喘、特应性皮炎和过敏性鼻炎等过敏性疾病的药物。
• EP2377851
  申请人：——

  公开号：——

  公开（公告）日：——
• US8461329B2
  申请人：——

  公开号：US8461329B2

  公开（公告）日：2013-06-11